New program aims to prevent diabetes in At-Risk students

NCT ID NCT06385015

Completed Prevention Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a special diabetes prevention program for college students at high risk for type 2 diabetes, especially those facing challenges like food or financial insecurity. 80 UCLA undergraduates with prediabetes or high risk were randomly assigned to either the program or a control group. The program included 19 group sessions with a lifestyle coach, focusing on healthy habits and weight loss. Researchers measured weight change and quality of life after 9 months to see if the program was effective and well-liked.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Tailored Diabetes Prevention Program (behavioral intervention with lifestyle coaching)
What this could lead to: If successful, this program could help prevent type 2 diabetes in high-risk young adults, especially those facing food or financial insecurity.
What could go wrong: This is a small, completed pilot study with only 80 participants, so results may not apply to larger or more diverse groups. Weight loss and quality-of-life improvements were measured, but long-term diabetes prevention was not directly assessed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2 PREDIABETES

Contacts and locations

Locations

University of California, Los Angeles

Los Angeles, California, 90095, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.